<DOC>
	<DOC>NCT00489658</DOC>
	<brief_summary>This case series study follows on a terminated randomised clinical trial in a nearby location of Uganda, in which the combination of eflornithine + nifurtimox showed very promising efficacy and safety. The study's purpose is to evaluate the efficacy and safety of this combination in a larger group of late-stage Human African trypanosomiasis (sleeping sickness) patients.</brief_summary>
	<brief_title>Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda</brief_title>
	<detailed_description />
	<mesh_term>Trypanosomiasis, African</mesh_term>
	<mesh_term>Trypanosomiasis</mesh_term>
	<mesh_term>Eflornithine</mesh_term>
	<mesh_term>Nifurtimox</mesh_term>
	<criteria>Stage 2 infection with Trypanosoma brucei gambiense diagnosed within the previous 14 days, as defined by either of the following: (i) Presence of trypanosomes in blood or lymph node fluid and WBC count in CSF &gt; 5 / mm3, or (ii) Presence of trypanosomes in the CSF with any CSF WBC count Residence in the study area Written informed consent (to be obtained from parent/guardian for children under 18 years and patients with impaired cognition) Pregnancy or clinical history suggestive thereof Weight &lt; 10 Kg History of any HAT treatment within the previous 24 months Inability to undergo hospitalisation or attend followup visits during the 24 months following discharge Severe anemia (Hb&lt; 5g/dl) Active tuberculosis (sputum positive) HIV positive (if patient has been tested and results are known) Severe renal or hepatic failure Bacterial or cryptococcal meningitis Other severe underlying diseases upon admission Refugee status</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Human African trypanosomiasis</keyword>
	<keyword>sleeping sickness</keyword>
	<keyword>Trypanosoma brucei gambiense</keyword>
	<keyword>combination</keyword>
	<keyword>eflornithine</keyword>
	<keyword>nifurtimox</keyword>
	<keyword>Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)</keyword>
</DOC>